- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03397472
Magnetic Field Modulation Pillow for Insomnia Clinical Trial
March 24, 2020 updated by: Guangdong Provincial People's Hospital
This interventional study was designed to explore the clinical effect of magnetic field modulation system on insomnia patients and provide a new solution for insomnia treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients with insomnia receiving this sleep pillow with magnetic system or not would be observed in months.The effect of sleep pillow with magnetic system for insomnia would evaluated.
Study Type
Interventional
Enrollment (Actual)
129
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Guangdong Genereal Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
1.18 to 65 years old. 2.Primary Insomnia
Exclusion Criteria:
- Secondary Insomnia
- Pilot, high-altitude operator
- Pregnant, lactating women
- Patients with serious disease
- The researchers believe that the candidates are not eligible
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: treatment group
use the sleep pillow with the magnetic field modulation treatment
|
use the device with magnetic field modulation to treat insomnia
|
|
Placebo Comparator: placebo group
use the sleep pillow without magnetic field modulation treatment
|
use the sleep pillow without magnetic field modulation treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pittsburgh Sleep Quality Index
Time Frame: 5 weeks
|
The Sleep Quality of Patients with insomnia as Reflected by PSQI scale.The PSQI scale, consisting of 18 self-rated items, was used to assess the subjects' sleep quality in the last month.The 18 self-rated items can be combined into seven factors: sleep quality, time to fall asleep, sleep duration, sleep efficiency, sleep disorders, hypnotic drugs, and daytime function.Each factor was scored on a scale of 0-3, and the total score of each factor was the total score of PSQI, with the total score ranging from 0-21.
The higher the score was, the worse the sleep quality was
|
5 weeks
|
|
Insomnia severity index
Time Frame: 5 weeks
|
The severity of insomnia was graded by ISI score,The total score of ISI was 8-14 for mild insomnia, 15-21 for moderate insomnia and 22 for severe insomnia.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parameters of sleep diary
Time Frame: 5 weeks
|
Some parameters of sleep diary
|
5 weeks
|
|
Response rate
Time Frame: 5 weeks
|
The total score of Insomnia severity index (ISI) decreased by 50% compared with that before treatment or less than 9 points after treatment will be judged to be responsive.
Total number of responsive subject after observation/total number of subject in the group*100%= response rate
|
5 weeks
|
|
Remission rate
Time Frame: 5 weeks
|
The total score of Insomnia severity index (ISI) less than 9 points after treatment will be judged to be remissive.
Total number of remissive subject after observation/total number of subject in the group*100%= remission rate
|
5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Qiong Ou, M.D., Guangdong Provincial People's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 18, 2018
Primary Completion (Actual)
December 30, 2019
Study Completion (Actual)
December 30, 2019
Study Registration Dates
First Submitted
January 4, 2018
First Submitted That Met QC Criteria
January 10, 2018
First Posted (Actual)
January 12, 2018
Study Record Updates
Last Update Posted (Actual)
March 25, 2020
Last Update Submitted That Met QC Criteria
March 24, 2020
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GDREC2017326H(R1)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Previous research plan submitted to the Ethics Committee has stated the participant information not be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
NYU Langone HealthNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedInsomniaUnited States
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
Clinical Trials on magnetic field modulation device
-
Mclean HospitalStanley Medical Research InstituteCompletedDepression | Bipolar Depression | Major Depressive DisorderUnited States
-
Mclean HospitalSuspendedBipolar Depression | Unipolar DepressionUnited States
-
University Hospital, GhentBioElectronics CorporationCompleted
-
Scion NeuroStimCentre for Addiction and Mental HealthRecruiting
-
Kyoto UniversityCompleted
-
The First Affiliated Hospital of Soochow UniversitySoochow UniversityCompletedIrritable Bowel Syndrome | Functional Magnetic Resonance Imaging | Repetitive Transcranial Magnetic Stimulation | Chronic Visceral PainChina
-
Weill Medical College of Cornell UniversityCompletedTreatment Resistant DepressionUnited States
-
University of SevilleCompleted
-
Monaldi HospitalRecruitingHeart Failure, SystolicItaly
-
Shanghai Wallaby Medical Technologies Co.,Inc.Phenox GmbH; Beijing Wallaby Medical Technologies Co.,Inc.RecruitingIntracranial AneurysmChina